Washington, DC – PRESS RELEASE – Today, Reps. Tulsi Gabbard (HI-02) and Carlos Curbelo (FL-26) led a group of bipartisan lawmakers in introducing The... CBD Business Boulder Botanical and Bioscience Labs to Open New Global Headquarters at Former GE Facility in Colorado

Washington, DC – PRESS RELEASE – Today, Reps. Tulsi Gabbard (HI-02) and Carlos Curbelo (FL-26) led a group of bipartisan lawmakers in introducing The Marijuana Data Collection Act. The act calls upon the National Academy of Sciences (NAS) to collect and synthesize relevant data and to generate a formal report to Congress quantifying the impact of statewide marijuana legalization on matters specific to public health, safety, the economy, and criminal justice, among other issues. 

Click here to watch the press conference.

Numerous published peer-reviewed studies have assessed the impact of state-regulated marijuana legalization on these issues, but despite the publication of these reports, a lack of consensus and acceptance of this data continue, particularly amongst members of Congress and the Department of Justice. 

NORML Political Director Justin Strekal said, “This report will ensure that federal discussions and policies specific to this issue are based upon the best and most reliable evidence available. The data collected and compiled by the National Academy of Sciences will help to guide future marijuana legislation at federal, state, and local levels. 

“This is not a marijuana bill, it is an information bill. No member of Congress can intellectually justify opposition to this legislation. Our public policy needs to be based on sound data and science, not gut feelings or fear-mongering. Approving the Marijuana Data Collection Act would provide legislators with reliable and fact-based information to help them decide what direction is most beneficial to society when it comes to marijuana policy. 

“We appreciate the leadership from both Representatives Gabbard and Curbelo for for emphasizing that marijuana policy be evidence-based and for tasking the National Academies with this important work.”

Thirty-one states, Washington, DC and the U.S. territories of Guam and Puerto Rico have enacted legislation specific to the physician-authorized use of cannabis, while an estimated 63 million Americans now reside in jurisdictions where anyone over the age of 21 may possess cannabis legally. Voters overwhelmingly support these policy changes. According to a 2018 CAP poll, 68 percent of Americans support full marijuana legalization and according to Quinnipiac University, 71 percent believe that states, not the federal government, should set marijuana policy.

To date, these statewide regulatory programs are operating largely as voters and politicians intended. The enactment of these policies have not negatively impacted workplace safety, crime rates, traffic safety, or youth use patterns. They have stimulated economic development and created hundreds of millions of dollars in new tax revenue. Specifically, a 2017 report estimates that 123,000 Americans are now working full-time in the cannabis industry. Tax revenues from states like Colorado, Oregon, and Washington now exceed initial projections. Further, numerous studies have identified an association between cannabis access and lower rates of opioid use, abuse, hospitalizations, and mortality.

Bill Overview:

  • This bill requires data collection and study with regard to the impact of state-regulated marijuana legalization on public health, safety, the economy, and criminal justice, among other issues.
  • Specifically, this bill requires the Secretary of HHS to coordinate with the DOJ, DOL, and states (to the greatest extent possible) and direct the NAS to publish a biannual study on the health, safety, and economic effects of state legalized marijuana programs.
  • The report would also outline best practices for state-led data collection, as well as recommendations to overcome any barriers preventing data collection and gaps in data.
MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )